BRCA1 and neoplasm: Western blotting and IHC analysis of tumor tissues indicated that rucaparib increased expression of the HR repair effectors BRCA1/2 and Rad51, while these molecules were reduced by the combination, suggesting that BKM120 sensitizes tumor tissues to the effect of rucaparib by suppressing HR repair in vivo.